COMT inhibitors in Parkinson's disease
Identifieur interne : 003836 ( Main/Exploration ); précédent : 003835; suivant : 003837COMT inhibitors in Parkinson's disease
Auteurs : J. Rivest [Canada] ; C. L. Barclay [Canada] ; O. Suchowersky [Canada]Source :
- Canadian journal of neurological sciences [ 0317-1671 ] ; 1999.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Antiparkinson Agents (metabolism), Catechol O-Methyltransferase Inhibitors, Catechol O-methyltransferase, Catechols (therapeutic use), Chemotherapy, Clinical Trials as Topic, Entacapone, Enzyme Inhibitors (therapeutic use), Enzyme inhibitor, Hepatitis, Human, Humans, Levodopa (metabolism), Parkinson Disease (drug therapy), Parkinson disease, Tolcapone, Toxicity, Treatment.
- MESH :
- chemical , metabolism : Antiparkinson Agents, Levodopa.
- chemical , therapeutic use : Catechols, Enzyme Inhibitors.
- chemical : Catechol O-Methyltransferase Inhibitors.
- drug therapy : Parkinson Disease.
- Clinical Trials as Topic, Humans.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 000D47
- to stream PascalFrancis, to step Curation: 001176
- to stream PascalFrancis, to step Checkpoint: 000C70
- to stream Main, to step Merge: 003E23
- to stream PubMed, to step Corpus: 001691
- to stream PubMed, to step Curation: 001691
- to stream PubMed, to step Checkpoint: 001691
- to stream Ncbi, to step Merge: 000046
- to stream Ncbi, to step Curation: 000046
- to stream Ncbi, to step Checkpoint: 000046
- to stream Main, to step Merge: 003C01
- to stream Main, to step Curation: 003836
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">COMT inhibitors in Parkinson's disease</title>
<author><name sortKey="Rivest, J" sort="Rivest, J" uniqKey="Rivest J" first="J." last="Rivest">J. Rivest</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre Universitaire de Santé de l'Estrie</s1>
<s2>Fleurimont, Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Centre Universitaire de Santé de l'Estrie</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Barclay, C L" sort="Barclay, C L" uniqKey="Barclay C" first="C. L." last="Barclay">C. L. Barclay</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>University of Ottawa</s1>
<s2>Ottawa, Ontario</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>University of Ottawa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Suchowersky, O" sort="Suchowersky, O" uniqKey="Suchowersky O" first="O." last="Suchowersky">O. Suchowersky</name>
<affiliation wicri:level="4"><inist:fA14 i1="03"><s1>University of Calgary</s1>
<s2>Calgary, Alberta</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
<orgName type="university">Université de Calgary</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">99-0456197</idno>
<date when="1999">1999</date>
<idno type="stanalyst">PASCAL 99-0456197 INIST</idno>
<idno type="RBID">Pascal:99-0456197</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D47</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001176</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000C70</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000C70</idno>
<idno type="wicri:doubleKey">0317-1671:1999:Rivest J:comt:inhibitors:in</idno>
<idno type="wicri:Area/Main/Merge">003E23</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:10451758</idno>
<idno type="wicri:Area/PubMed/Corpus">001691</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001691</idno>
<idno type="wicri:Area/PubMed/Curation">001691</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001691</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001691</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001691</idno>
<idno type="wicri:Area/Ncbi/Merge">000046</idno>
<idno type="wicri:Area/Ncbi/Curation">000046</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000046</idno>
<idno type="wicri:doubleKey">0317-1671:1999:Rivest J:comt:inhibitors:in</idno>
<idno type="wicri:Area/Main/Merge">003C01</idno>
<idno type="wicri:Area/Main/Curation">003836</idno>
<idno type="wicri:Area/Main/Exploration">003836</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">COMT inhibitors in Parkinson's disease</title>
<author><name sortKey="Rivest, J" sort="Rivest, J" uniqKey="Rivest J" first="J." last="Rivest">J. Rivest</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Centre Universitaire de Santé de l'Estrie</s1>
<s2>Fleurimont, Quebec</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>Centre Universitaire de Santé de l'Estrie</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Barclay, C L" sort="Barclay, C L" uniqKey="Barclay C" first="C. L." last="Barclay">C. L. Barclay</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>University of Ottawa</s1>
<s2>Ottawa, Ontario</s2>
<s3>CAN</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<wicri:noRegion>University of Ottawa</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Suchowersky, O" sort="Suchowersky, O" uniqKey="Suchowersky O" first="O." last="Suchowersky">O. Suchowersky</name>
<affiliation wicri:level="4"><inist:fA14 i1="03"><s1>University of Calgary</s1>
<s2>Calgary, Alberta</s2>
<s3>CAN</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Canada</country>
<placeName><settlement type="city">Calgary</settlement>
<region type="state">Alberta</region>
</placeName>
<orgName type="university">Université de Calgary</orgName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Canadian journal of neurological sciences</title>
<title level="j" type="abbreviated">Can. j. neurol. sci.</title>
<idno type="ISSN">0317-1671</idno>
<imprint><date when="1999">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Canadian journal of neurological sciences</title>
<title level="j" type="abbreviated">Can. j. neurol. sci.</title>
<idno type="ISSN">0317-1671</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (metabolism)</term>
<term>Catechol O-Methyltransferase Inhibitors</term>
<term>Catechol O-methyltransferase</term>
<term>Catechols (therapeutic use)</term>
<term>Chemotherapy</term>
<term>Clinical Trials as Topic</term>
<term>Entacapone</term>
<term>Enzyme Inhibitors (therapeutic use)</term>
<term>Enzyme inhibitor</term>
<term>Hepatitis</term>
<term>Human</term>
<term>Humans</term>
<term>Levodopa (metabolism)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson disease</term>
<term>Tolcapone</term>
<term>Toxicity</term>
<term>Treatment</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Catechols</term>
<term>Enzyme Inhibitors</term>
</keywords>
<keywords scheme="MESH" type="chemical" xml:lang="en"><term>Catechol O-Methyltransferase Inhibitors</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Clinical Trials as Topic</term>
<term>Humans</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Inhibiteur enzyme</term>
<term>Catechol O-methyltransferase</term>
<term>Hépatite</term>
<term>Entacapone</term>
<term>Tolcapone</term>
<term>Chimiothérapie</term>
<term>Traitement</term>
<term>Toxicité</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
<region><li>Alberta</li>
</region>
<settlement><li>Calgary</li>
</settlement>
<orgName><li>Université de Calgary</li>
</orgName>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Rivest, J" sort="Rivest, J" uniqKey="Rivest J" first="J." last="Rivest">J. Rivest</name>
</noRegion>
<name sortKey="Barclay, C L" sort="Barclay, C L" uniqKey="Barclay C" first="C. L." last="Barclay">C. L. Barclay</name>
<name sortKey="Suchowersky, O" sort="Suchowersky, O" uniqKey="Suchowersky O" first="O." last="Suchowersky">O. Suchowersky</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003836 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003836 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Main |étape= Exploration |type= RBID |clé= Pascal:99-0456197 |texte= COMT inhibitors in Parkinson's disease }}
This area was generated with Dilib version V0.6.29. |